|
Volumn 363, Issue 9421, 2004, Pages 1570-
|
Statins for the treatment of multiple sclerosis: Cautious hope
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATORVASTATIN;
BETA1A INTERFERON;
CYTOKINE;
GAMMA INTERFERON;
GLATIRAMER;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
HYPOCHOLESTEROLEMIC AGENT;
IMMUNOMODULATING AGENT;
INTERFERON BETA SERINE;
INTERLEUKIN 12;
MEVINOLIN;
MITOXANTRONE;
SIMVASTATIN;
ANTIINFLAMMATORY ACTIVITY;
CELL PROLIFERATION;
CENTRAL NERVOUS SYSTEM INFECTION;
CHOLESTEROL INTAKE;
CLINICAL TRIAL;
DRUG MECHANISM;
DRUG POTENCY;
DRUG SAFETY;
ENCEPHALOMYELITIS;
HUMAN;
IMMUNOLOGICAL PROCEDURES;
IMMUNOMODULATION;
INFLAMMATORY DISEASE;
INTERMETHOD COMPARISON;
LEUKOCYTE AGGREGATION;
MONOTHERAPY;
MULTIPLE SCLEROSIS;
NONHUMAN;
NOTE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PARALYSIS;
PRIORITY JOURNAL;
SIDE EFFECT;
TREATMENT OUTCOME;
|
EID: 2442561772
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(04)16237-5 Document Type: Note |
Times cited : (12)
|
References (5)
|